InfoClip XTRA and Capsule DotClip will be back week of August 3, 2015. In the meantime, you can review all the year to date news and information at infoclip.ca.
Have a great holiday!
InfoClip XTRA and Capsule DotClip will be back week of August 3, 2015. In the meantime, you can review all the year to date news and information at infoclip.ca.
Have a great holiday!
InfoClip XTRA and Capsule DotClip will be back week of August 3, 2015. In the meantime, you can review all the year to date news and information at infoclip.ca.
Have a great holiday!
Irish optical software company Ocuco has acquired the optical business assets of Burlington, Ontario, based Acumenex, an e-Commerce company that services eye care practitioners in the United States and Canada.
Ocuco will add Acumenex’s webstore and supply chain integration capabilities into its own optical practice management software as part of Ocuco’s omni-channel strategy.
Ocuco is a provider of optical lab and practice management software suites to 8,000 clients, including FYi Doctors in Canada.
Pictured above: Leo MacCanna, CEO Ocuco (L), Rick Spencer, former CEO Acumenex (R)
MARIUS MOREL offers a gold-plated version of the men’s ASPHALT concept for a timeless product.
Simple lines decorated with gold adds refinement and durability. The frames are supplied with a guarantee card, case and MARIUS MOREL GOLD individual shopping bag.
Distributed by Lanctôt: www.rlanctot.com
Cole Haan announces a multiyear global license agreement with Altair, a division of Marchon to design, manufacture and distribute their sunglasses and ophthalmic eyewear collections beginning fall 2015. In Canada, the collection will be available through Marchon Eyewear.
“Cole Haan is an iconic American brand with a renowned heritage and classic design that is seamlessly executed through each of their product categories. Their skillful craftsmanship and eye for high quality will easily translate to eyewear that the Cole Haan consumer will appreciate,” said Altair Eyewear President, Steve Wright.
“We are delighted to announce the launch of Cole Haan eyewear and our global partnership with Altair. They have developed a collection that is both iconic and timeless. Our customers all over the world will love what Altair has accomplished,” commented Cole Haan’s Chief Marketing Officer, David Maddocks.
Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.
Learn MoreNow available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.
Read moreAYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.
Read moreThe Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.
Read moreBausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.
Read more
Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.
Learn MoreNow available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.
Read MoreAYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.
Read MoreThe Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.
Read MoreBausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.
Read More
Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.
Learn MoreNow available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.
Read moreAYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.
Read moreThe Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.
Read moreBausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.
Read more
Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.
Learn MoreNow available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.
Read moreAYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.
Read moreThe Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.
Read moreBausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.
Read more